REGULATORY INTELLIGENCE·Warning Letter
FDA Class II Recall: RemedyRepack's TraMADol HCl Contamination Exposes Critical Repackaging Risks
RemedyRepack Inc.'s Class II recall of 23,970 TraMADol HCl 50 mg tablets due to baclofen contamination highlights severe quality control deficiencies in pharmaceutical repackaging. This incident, coupled with a prior recall for dissolution failure, necessitates immediate review of supplier qualification processes by procurement directors and supply chain VPs to mitigate significant patient safety and business risks.
90-Day Activity